Clinical Trial Update: Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the quadrivalent influenza HA stem vaccine VRC-FLUMOS0122-00-VP (SteMos1) with and without ALFQ adjuvant in healthy adults. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Drugs mentioned

• ALFQ Adjuvant (Army Liposomal Formulation containing QS-21 (ALFQ))
• VRC-FLUMOS0122-00-VP (SteMos1) Quadrivalent Influenza HA Stem Vaccine (Quadrivalent influenza HA stem vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza Prevention, Pandemic Influenza Prevention | Phase 1 | Status: RECRUITING